305 Grattan Street
Parkville
Melbourne
Australia
Peter MacCallum Cancer Centre
Non-small cell lung cancer, NSCLC, immune checkpoint inhibitors, anti-TIGIT monoclonal antibody, PD-L1 inhibitor, atezolizumab, tiragolumab, cancer immunotherapy
Lung cancer, Immunotherapy, pembrolizumab, Real world outcomes